| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
131,735 |
123,270 |
$45.60M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
49,116 |
45,181 |
$29.87M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
29,526 |
28,163 |
$29.41M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,941 |
46,423 |
$23.00M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
89,820 |
85,313 |
$18.59M |
| 70450 |
Computed tomography, head or brain; without contrast material |
26,651 |
24,906 |
$10.74M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,283 |
3,194 |
$3.98M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
8,761 |
8,299 |
$3.93M |
| 93975 |
|
12,512 |
11,913 |
$3.69M |
| T1015 |
Clinic visit/encounter, all-inclusive |
14,304 |
10,326 |
$3.56M |
| G0378 |
Hospital observation service, per hour |
37,065 |
17,592 |
$3.51M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
7,853 |
7,566 |
$3.09M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
40,468 |
19,339 |
$2.87M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,728 |
3,592 |
$2.66M |
| 44970 |
|
394 |
391 |
$2.61M |
| T1016 |
Case management, each 15 minutes |
24,778 |
6,053 |
$2.15M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15,376 |
14,895 |
$2.15M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
5,964 |
5,715 |
$2.11M |
| 80053 |
Comprehensive metabolic panel |
192,044 |
165,357 |
$2.02M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
114,299 |
102,322 |
$1.95M |
| 16020 |
|
13,543 |
8,676 |
$1.82M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,346 |
2,295 |
$1.77M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
126,215 |
114,232 |
$1.72M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,610 |
1,532 |
$1.61M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,699 |
2,553 |
$1.55M |
| 47562 |
|
218 |
215 |
$1.47M |
| 92587 |
|
2,954 |
2,887 |
$1.41M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
98,703 |
75,457 |
$1.24M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
663 |
640 |
$1.08M |
| 74174 |
|
879 |
853 |
$1.05M |
| 20610 |
|
3,370 |
2,643 |
$1.00M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
23,706 |
12,639 |
$946K |
| 72131 |
|
4,615 |
4,398 |
$935K |
| 12001 |
|
2,517 |
2,445 |
$899K |
| 70498 |
|
2,344 |
2,272 |
$869K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
11,736 |
11,498 |
$818K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
16,384 |
15,756 |
$766K |
| 94060 |
|
2,145 |
2,082 |
$761K |
| 93970 |
|
3,519 |
3,373 |
$754K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,750 |
1,355 |
$723K |
| 93976 |
|
16,635 |
16,008 |
$718K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
535 |
514 |
$675K |
| 73110 |
|
8,053 |
6,732 |
$671K |
| 70491 |
|
1,275 |
1,224 |
$619K |
| 99215 |
Prolong outpt/office vis |
19,592 |
17,065 |
$596K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,296 |
1,255 |
$568K |
| 76642 |
|
4,490 |
4,325 |
$565K |
| 12002 |
|
1,817 |
1,755 |
$555K |
| 73130 |
|
10,912 |
9,395 |
$541K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
4,507 |
4,151 |
$536K |
| 87536 |
|
5,495 |
5,178 |
$517K |
| 73630 |
|
11,959 |
11,019 |
$516K |
| 72141 |
|
1,082 |
1,034 |
$511K |
| 73610 |
|
8,999 |
8,145 |
$484K |
| 71046 |
Radiologic examination, chest; 2 views |
50,402 |
47,673 |
$484K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
849 |
823 |
$465K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
107,759 |
90,101 |
$456K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
438 |
416 |
$447K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,625 |
2,551 |
$443K |
| 12011 |
|
1,727 |
1,686 |
$439K |
| 10060 |
|
2,405 |
2,321 |
$439K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,856 |
1,735 |
$435K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
17,415 |
12,120 |
$401K |
| 20611 |
|
2,018 |
1,806 |
$394K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
10,738 |
10,315 |
$384K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30,591 |
29,055 |
$380K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,006 |
1,944 |
$377K |
| 29125 |
|
1,427 |
1,332 |
$364K |
| 76830 |
Ultrasound, transvaginal |
8,832 |
8,490 |
$342K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,852 |
2,790 |
$341K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,383 |
1,334 |
$336K |
| 74183 |
|
721 |
685 |
$319K |
| H0031 |
Mental health assessment, by non-physician |
619 |
575 |
$315K |
| 92557 |
|
3,352 |
3,286 |
$315K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
2,216 |
2,177 |
$299K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,702 |
1,636 |
$297K |
| 76536 |
|
2,846 |
2,777 |
$297K |
| 80074 |
|
5,452 |
5,189 |
$287K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
6,438 |
6,091 |
$285K |
| 97602 |
|
2,155 |
1,532 |
$280K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
54,001 |
46,201 |
$277K |
| 94010 |
|
1,480 |
1,444 |
$274K |
| 73030 |
|
8,066 |
7,436 |
$257K |
| 97165 |
|
11,103 |
10,458 |
$255K |
| 73564 |
|
2,217 |
2,132 |
$250K |
| 73080 |
|
4,090 |
3,655 |
$247K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15,762 |
9,965 |
$243K |
| 73700 |
|
785 |
750 |
$242K |
| 76770 |
|
2,756 |
2,701 |
$240K |
| 97597 |
|
1,679 |
1,310 |
$235K |
| 73562 |
|
9,111 |
8,631 |
$235K |
| 73140 |
|
4,364 |
3,766 |
$230K |
| 71250 |
|
2,157 |
2,088 |
$229K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
33,959 |
30,497 |
$226K |
| H0038 |
Self-help/peer services, per 15 minutes |
1,870 |
1,017 |
$223K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
146 |
140 |
$215K |
| 70486 |
|
3,952 |
3,784 |
$185K |
| H2014 |
Skills training and development, per 15 minutes |
852 |
350 |
$183K |
| 93971 |
|
4,597 |
4,368 |
$181K |
| H2027 |
Psychoeducational service, per 15 minutes |
1,142 |
521 |
$179K |
| 94726 |
|
1,441 |
1,402 |
$169K |
| 73590 |
|
4,837 |
4,468 |
$169K |
| 92083 |
|
1,654 |
1,594 |
$168K |
| 99464 |
|
3,000 |
2,970 |
$168K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
15,419 |
13,879 |
$149K |
| 76882 |
|
3,078 |
2,975 |
$142K |
| 73090 |
|
4,233 |
3,702 |
$141K |
| 19083 |
|
111 |
109 |
$139K |
| 77080 |
|
1,710 |
1,619 |
$139K |
| 93226 |
|
713 |
704 |
$138K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,226 |
1,210 |
$137K |
| 72100 |
|
2,302 |
2,255 |
$130K |
| C1769 |
Guide wire |
1,213 |
1,113 |
$127K |
| 29515 |
|
515 |
466 |
$125K |
| 73560 |
|
2,372 |
2,174 |
$118K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
108 |
96 |
$118K |
| 86480 |
|
4,374 |
4,167 |
$117K |
| 97161 |
|
9,893 |
9,428 |
$116K |
| 81599 |
|
771 |
735 |
$113K |
| 74018 |
|
4,894 |
4,297 |
$112K |
| 86003 |
|
763 |
533 |
$109K |
| 77066 |
Tomosynthesis, mammo |
2,814 |
2,724 |
$106K |
| 92250 |
|
1,281 |
1,247 |
$106K |
| 84443 |
Thyroid stimulating hormone (TSH) |
31,221 |
29,541 |
$105K |
| 87522 |
Neg quan hep c or qual rna |
3,396 |
3,235 |
$104K |
| 73221 |
|
462 |
440 |
$102K |
| 11721 |
|
2,788 |
2,680 |
$102K |
| 70496 |
|
2,078 |
1,997 |
$100K |
| 87902 |
|
212 |
205 |
$98K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
193,625 |
164,155 |
$97K |
| 71271 |
|
1,170 |
1,126 |
$92K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
399 |
352 |
$92K |
| 16025 |
|
584 |
404 |
$89K |
| 72110 |
|
955 |
941 |
$88K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
72,622 |
66,086 |
$85K |
| 70487 |
|
156 |
154 |
$83K |
| 73502 |
|
3,687 |
3,526 |
$78K |
| 74220 |
|
395 |
388 |
$77K |
| 93017 |
|
1,325 |
1,254 |
$75K |
| 80061 |
Lipid panel |
33,657 |
32,000 |
$74K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,395 |
2,162 |
$73K |
| 73701 |
|
110 |
105 |
$72K |
| 97168 |
|
1,924 |
1,716 |
$69K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
41 |
39 |
$68K |
| 59025 |
Fetal non-stress test |
3,162 |
2,676 |
$68K |
| 11055 |
|
506 |
464 |
$64K |
| 74160 |
|
195 |
183 |
$64K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,932 |
4,741 |
$64K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
552 |
536 |
$63K |
| 73552 |
|
2,166 |
2,043 |
$63K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
47,213 |
36,320 |
$61K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,563 |
9,953 |
$60K |
| 73070 |
|
895 |
814 |
$58K |
| 72050 |
|
372 |
359 |
$58K |
| 95908 |
|
177 |
174 |
$57K |
| 73060 |
|
1,885 |
1,726 |
$56K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
629 |
387 |
$55K |
| 77065 |
Tomosynthesis, mammo |
2,302 |
2,171 |
$54K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,665 |
2,577 |
$49K |
| 87507 |
|
528 |
513 |
$49K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,797 |
1,745 |
$49K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
8,658 |
4,855 |
$48K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
31,258 |
28,493 |
$48K |
| 11056 |
|
442 |
418 |
$47K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
66 |
65 |
$46K |
| 97760 |
|
4,833 |
4,125 |
$45K |
| 80076 |
|
2,576 |
2,462 |
$44K |
| 36430 |
|
952 |
760 |
$44K |
| 74230 |
|
270 |
261 |
$44K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,743 |
2,545 |
$44K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,935 |
1,873 |
$41K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
14,371 |
13,842 |
$41K |
| 93308 |
|
1,188 |
1,137 |
$39K |
| 72128 |
|
3,565 |
3,381 |
$39K |
| 82274 |
|
7,324 |
7,051 |
$37K |
| 11100 |
|
108 |
107 |
$36K |
| A6198 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing |
3,358 |
2,491 |
$35K |
| 92228 |
|
937 |
923 |
$35K |
| 76775 |
|
700 |
677 |
$33K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
513 |
472 |
$32K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
73,534 |
59,726 |
$31K |
| T1002 |
Rn services, up to 15 minutes |
3,914 |
2,361 |
$31K |
| 72040 |
|
770 |
758 |
$31K |
| 71045 |
Radiologic examination, chest; single view |
27,849 |
25,773 |
$30K |
| 73000 |
|
454 |
412 |
$30K |
| 92136 |
|
317 |
298 |
$29K |
| 86235 |
|
745 |
396 |
$29K |
| 72114 |
|
264 |
251 |
$28K |
| 90677 |
|
579 |
570 |
$28K |
| 84702 |
|
10,429 |
9,006 |
$27K |
| 76801 |
|
4,516 |
4,166 |
$27K |
| 80320 |
|
22,835 |
20,621 |
$26K |
| 76942 |
|
262 |
246 |
$26K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
51,984 |
41,834 |
$25K |
| 84403 |
|
1,471 |
1,395 |
$25K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
22,246 |
21,060 |
$25K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
1,366 |
1,244 |
$25K |
| 96367 |
|
3,234 |
2,802 |
$23K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,245 |
437 |
$22K |
| 82746 |
|
3,714 |
3,501 |
$22K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
42 |
40 |
$22K |
| 93923 |
|
312 |
304 |
$22K |
| 51702 |
|
1,769 |
1,511 |
$22K |
| 90670 |
|
1,652 |
1,521 |
$21K |
| 81513 |
|
306 |
295 |
$20K |
| 29075 |
|
165 |
156 |
$20K |
| 16030 |
|
50 |
39 |
$20K |
| 90746 |
|
417 |
397 |
$20K |
| J1756 |
Injection, iron sucrose, 1 mg |
665 |
368 |
$19K |
| 95819 |
|
82 |
76 |
$19K |
| 29065 |
|
616 |
531 |
$19K |
| 92579 |
|
642 |
627 |
$18K |
| 86803 |
|
16,397 |
15,762 |
$18K |
| 87631 |
|
6,824 |
6,576 |
$18K |
| 74019 |
|
1,806 |
1,761 |
$17K |
| 12013 |
|
76 |
75 |
$17K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
126 |
55 |
$17K |
| 96523 |
|
292 |
270 |
$17K |
| 95909 |
|
51 |
51 |
$17K |
| 49083 |
|
19 |
13 |
$16K |
| 93880 |
|
185 |
171 |
$16K |
| 73200 |
|
52 |
50 |
$16K |
| 82607 |
|
6,408 |
6,063 |
$16K |
| 51798 |
|
712 |
658 |
$16K |
| 72170 |
|
490 |
466 |
$16K |
| 11750 |
|
85 |
66 |
$16K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14,727 |
14,050 |
$16K |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
4,015 |
2,121 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
17,703 |
16,791 |
$14K |
| 87338 |
|
2,671 |
2,611 |
$14K |
| 86850 |
|
9,903 |
9,055 |
$14K |
| 76870 |
|
2,153 |
2,063 |
$14K |
| J0897 |
Injection, denosumab, 1 mg |
26 |
24 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
11,380 |
8,723 |
$14K |
| 73521 |
|
451 |
438 |
$14K |
| 29085 |
|
56 |
45 |
$13K |
| 85027 |
|
22,095 |
19,347 |
$13K |
| 97802 |
|
332 |
329 |
$12K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
1,030 |
895 |
$12K |
| 87070 |
|
3,878 |
3,425 |
$12K |
| 29105 |
|
39 |
36 |
$12K |
| 92002 |
|
88 |
86 |
$11K |
| 92585 |
|
44 |
40 |
$11K |
| A4648 |
Tissue marker, implantable, any type, each |
203 |
190 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
44,390 |
42,129 |
$10K |
| 88341 |
|
586 |
321 |
$10K |
| 73660 |
|
620 |
590 |
$10K |
| 99153 |
Mod sedat endo service >5yrs |
1,074 |
992 |
$10K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
772 |
598 |
$9K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
43,161 |
41,563 |
$9K |
| 72070 |
|
580 |
562 |
$9K |
| 90715 |
|
10,134 |
9,783 |
$9K |
| J7318 |
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg |
31 |
29 |
$9K |
| 76885 |
|
88 |
87 |
$9K |
| 10022 |
|
12 |
12 |
$8K |
| 84165 |
|
634 |
613 |
$8K |
| 83970 |
|
1,349 |
1,245 |
$8K |
| 95860 |
|
68 |
68 |
$8K |
| 73100 |
|
81 |
67 |
$8K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,971 |
6,297 |
$8K |
| 92134 |
|
4,148 |
3,814 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14,479 |
14,182 |
$7K |
| J2785 |
Injection, regadenoson, 0.1 mg |
326 |
302 |
$7K |
| 87186 |
|
12,794 |
11,341 |
$7K |
| 83880 |
|
9,756 |
9,092 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,168 |
976 |
$6K |
| 82550 |
|
15,919 |
13,230 |
$6K |
| 80164 |
|
975 |
833 |
$6K |
| 83516 |
|
2,759 |
2,095 |
$6K |
| 11730 |
|
26 |
24 |
$6K |
| 91322 |
|
350 |
340 |
$6K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
109 |
100 |
$6K |
| 97803 |
|
237 |
235 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,694 |
1,332 |
$6K |
| 94761 |
|
2,111 |
1,745 |
$5K |
| 82247 |
|
1,812 |
1,481 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,258 |
2,129 |
$5K |
| 95816 |
|
27 |
26 |
$5K |
| 92567 |
|
5,317 |
5,178 |
$5K |
| 84153 |
|
1,859 |
1,744 |
$5K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,609 |
2,054 |
$5K |
| 95910 |
|
12 |
12 |
$5K |
| 86635 |
|
2,009 |
1,756 |
$5K |
| 92523 |
|
117 |
111 |
$5K |
| 11102 |
|
16 |
16 |
$4K |
| 17250 |
|
15 |
13 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,009 |
955 |
$4K |
| 88312 |
|
3,680 |
2,191 |
$4K |
| A9270 |
Non-covered item or service |
9,979 |
4,772 |
$4K |
| 31500 |
|
40 |
39 |
$4K |
| 82728 |
|
5,655 |
5,385 |
$4K |
| 92950 |
|
45 |
41 |
$4K |
| 97162 |
|
559 |
525 |
$4K |
| 81001 |
|
99,646 |
92,065 |
$4K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
7,511 |
4,891 |
$4K |
| 88304 |
|
3,316 |
2,819 |
$4K |
| 84445 |
|
82 |
79 |
$4K |
| 90686 |
|
2,772 |
2,566 |
$4K |
| 84146 |
|
645 |
602 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
39,868 |
37,752 |
$4K |
| 94618 |
|
214 |
195 |
$4K |
| 73120 |
|
45 |
39 |
$3K |
| G0127 |
Trimming of dystrophic nails, any number |
284 |
276 |
$3K |
| 99442 |
|
302 |
284 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
9,121 |
8,826 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
42 |
38 |
$3K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
521 |
465 |
$3K |
| 64400 |
|
59 |
56 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
140 |
94 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
17,702 |
16,787 |
$3K |
| 72190 |
|
18 |
14 |
$3K |
| 82533 |
|
105 |
93 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,414 |
1,148 |
$3K |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
8,018 |
5,791 |
$3K |
| 76604 |
|
113 |
112 |
$3K |
| 99360 |
|
2,541 |
1,336 |
$3K |
| 73600 |
|
28 |
27 |
$3K |
| 36591 |
|
959 |
641 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,206 |
3,923 |
$3K |
| 0450 |
Emergency room services |
64 |
60 |
$3K |
| 85730 |
|
6,487 |
5,611 |
$3K |
| 88342 |
|
1,641 |
1,298 |
$3K |
| A6209 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
1,902 |
1,749 |
$3K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
761 |
356 |
$3K |
| 82803 |
|
2,668 |
2,353 |
$2K |
| 86704 |
|
1,847 |
1,771 |
$2K |
| 90739 |
|
13 |
13 |
$2K |
| 87045 |
|
380 |
367 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14,929 |
14,215 |
$2K |
| 83690 |
|
50,993 |
46,999 |
$2K |
| 82570 |
|
14,126 |
13,300 |
$2K |
| 84484 |
|
46,561 |
35,313 |
$2K |
| 85610 |
|
52,614 |
46,705 |
$2K |
| 76512 |
|
27 |
26 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,500 |
1,375 |
$2K |
| 69210 |
|
72 |
70 |
$2K |
| 90736 |
|
108 |
94 |
$2K |
| 86331 |
|
926 |
892 |
$2K |
| 11057 |
|
14 |
13 |
$2K |
| 84030 |
|
355 |
353 |
$2K |
| 83001 |
|
408 |
395 |
$2K |
| 72146 |
|
13 |
13 |
$2K |
| 84703 |
|
37,402 |
34,622 |
$2K |
| 86708 |
|
1,570 |
1,500 |
$2K |
| 62270 |
|
25 |
25 |
$2K |
| 90662 |
|
1,712 |
1,546 |
$2K |
| T1019 |
Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) |
587 |
259 |
$2K |
| 86360 |
|
5,632 |
5,217 |
$2K |
| 81025 |
|
26,483 |
25,377 |
$2K |
| 70480 |
|
12 |
12 |
$2K |
| 88112 |
|
1,508 |
1,288 |
$2K |
| 73565 |
|
26 |
26 |
$2K |
| 82950 |
|
989 |
976 |
$2K |
| 90732 |
|
1,784 |
1,659 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
61,003 |
49,598 |
$2K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,715 |
693 |
$2K |
| 95861 |
|
14 |
14 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,353 |
2,816 |
$1K |
| 29405 |
|
16 |
14 |
$1K |
| 96376 |
|
17,030 |
12,788 |
$1K |
| 77073 |
|
14 |
12 |
$1K |
| 86141 |
|
9,699 |
9,162 |
$1K |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
3,667 |
3,567 |
$1K |
| 96368 |
|
651 |
605 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
360 |
345 |
$1K |
| 82784 |
|
1,295 |
1,058 |
$1K |
| 83655 |
|
587 |
583 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
66,502 |
49,542 |
$1K |
| 93242 |
|
20 |
20 |
$1K |
| 73620 |
|
53 |
51 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
46,652 |
39,641 |
$1K |
| 86592 |
|
9,758 |
9,206 |
$1K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
652 |
570 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
270,718 |
225,340 |
$1K |
| 71101 |
|
43 |
42 |
$1K |
| 70360 |
|
79 |
77 |
$978.74 |
| 0064A |
|
297 |
276 |
$935.03 |
| 83735 |
|
19,515 |
14,669 |
$869.91 |
| 0134A |
|
221 |
198 |
$867.14 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
20 |
20 |
$828.81 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
38 |
35 |
$822.80 |
| 86923 |
|
576 |
468 |
$811.73 |
| 90832 |
Psychotherapy, 30 minutes with patient |
16 |
12 |
$806.65 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
49,255 |
42,429 |
$795.70 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
23,302 |
19,825 |
$770.87 |
| 90837 |
Psychotherapy, 53 minutes with patient |
23 |
12 |
$753.98 |
| 0004A |
|
22 |
21 |
$751.22 |
| 95885 |
|
176 |
169 |
$733.94 |
| 87102 |
|
819 |
728 |
$733.93 |
| 84156 |
|
3,825 |
3,565 |
$728.04 |
| 86225 |
|
1,426 |
1,369 |
$719.29 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,320 |
1,261 |
$718.44 |
| 86706 |
|
2,483 |
2,383 |
$708.74 |
| J2704 |
Injection, propofol, 10 mg |
18,038 |
16,547 |
$708.12 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
225 |
219 |
$702.58 |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$696.66 |
| 86703 |
|
46 |
44 |
$647.74 |
| 82105 |
|
1,177 |
1,129 |
$623.18 |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
18 |
13 |
$613.72 |
| 93280 |
|
18 |
15 |
$608.05 |
| 86780 |
|
4,907 |
4,552 |
$603.23 |
| 97763 |
|
43 |
39 |
$599.02 |
| 83550 |
|
5,608 |
5,342 |
$577.02 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
24,863 |
20,356 |
$576.43 |
| 86255 |
|
177 |
162 |
$565.80 |
| S5110 |
Home care training, family; per 15 minutes |
60 |
24 |
$563.40 |
| 85379 |
|
6,188 |
5,947 |
$557.80 |
| 87077 |
|
12,782 |
11,337 |
$553.03 |
| 11720 |
|
15 |
14 |
$546.66 |
| 87486 |
|
1,317 |
1,300 |
$496.14 |
| 99441 |
|
98 |
96 |
$494.05 |
| 87040 |
|
14,370 |
7,906 |
$479.07 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
1,605 |
1,358 |
$477.36 |
| 99443 |
|
57 |
52 |
$465.75 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,110 |
1,912 |
$458.35 |
| 84439 |
|
7,776 |
7,421 |
$458.21 |
| 92133 |
|
1,522 |
1,469 |
$448.60 |
| 90750 |
|
284 |
268 |
$436.87 |
| 83605 |
|
14,874 |
11,376 |
$425.83 |
| 87210 |
|
9,938 |
9,543 |
$404.41 |
| 82150 |
|
396 |
373 |
$385.87 |
| 97164 |
|
205 |
200 |
$382.03 |
| 86039 |
|
88 |
84 |
$372.36 |
| 82140 |
|
2,307 |
2,091 |
$365.14 |
| 86901 |
|
13,479 |
12,450 |
$354.09 |
| A6211 |
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing |
13 |
12 |
$349.31 |
| 95012 |
|
155 |
153 |
$341.13 |
| 87177 |
|
60 |
58 |
$334.21 |
| 87517 |
|
100 |
94 |
$327.47 |
| 82652 |
|
100 |
94 |
$323.08 |
| 82565 |
|
1,653 |
1,593 |
$316.04 |
| 90834 |
Psychotherapy, 45 minutes with patient |
18 |
13 |
$311.22 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
202 |
141 |
$307.62 |
| 94644 |
|
2,099 |
1,992 |
$300.16 |
| 86900 |
|
13,480 |
12,448 |
$274.45 |
| 85055 |
|
4,899 |
3,731 |
$263.96 |
| 87116 |
|
572 |
495 |
$253.22 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17,060 |
14,394 |
$253.05 |
| 83615 |
|
2,640 |
2,414 |
$253.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
53 |
49 |
$252.97 |
| 83921 |
|
120 |
110 |
$249.98 |
| J1953 |
Injection, levetiracetam, 10 mg |
1,091 |
875 |
$248.00 |
| 85007 |
|
21,665 |
19,131 |
$244.66 |
| 83993 |
|
27 |
27 |
$244.46 |
| 90656 |
|
225 |
222 |
$241.08 |
| 80069 |
|
44 |
44 |
$238.33 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
25 |
25 |
$217.07 |
| 86762 |
|
786 |
753 |
$214.41 |
| 88173 |
|
85 |
67 |
$208.52 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14,628 |
11,086 |
$207.50 |
| G0008 |
Administration of influenza virus vaccine |
8,795 |
8,144 |
$205.20 |
| 87449 |
|
2,148 |
1,760 |
$189.98 |
| 87430 |
|
3,929 |
3,834 |
$186.66 |
| 81003 |
|
9,807 |
9,053 |
$185.52 |
| 87150 |
|
402 |
382 |
$174.68 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,283 |
2,144 |
$174.08 |
| 87340 |
|
3,707 |
3,537 |
$170.38 |
| 83021 |
|
52 |
51 |
$169.32 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
480 |
462 |
$165.98 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
270 |
253 |
$153.89 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
32 |
25 |
$151.70 |
| 82010 |
|
1,541 |
1,404 |
$148.52 |
| 86431 |
|
1,711 |
1,633 |
$139.84 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
991 |
603 |
$137.91 |
| 86769 |
|
25 |
24 |
$134.83 |
| 92526 |
|
216 |
199 |
$132.98 |
| 80179 |
|
3,747 |
3,532 |
$131.77 |
| 80143 |
|
3,823 |
3,592 |
$131.77 |
| 84145 |
|
924 |
880 |
$131.02 |
| 87581 |
|
1,316 |
1,299 |
$130.00 |
| 82330 |
|
677 |
595 |
$128.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14,910 |
13,357 |
$122.77 |
| 82962 |
|
8,214 |
4,661 |
$117.12 |
| 84466 |
|
56 |
50 |
$117.09 |
| 87205 |
|
5,624 |
4,846 |
$115.77 |
| 97018 |
|
1,079 |
490 |
$114.77 |
| A6213 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
12 |
12 |
$113.37 |
| 84550 |
|
2,486 |
2,297 |
$112.08 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,089 |
2,967 |
$110.00 |
| 84480 |
|
1,846 |
1,762 |
$109.38 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
26,592 |
22,252 |
$109.38 |
| 87081 |
|
3,056 |
2,995 |
$100.80 |
| 80178 |
|
145 |
115 |
$95.60 |
| 88108 |
|
27 |
25 |
$93.42 |
| L0172 |
Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf |
1,133 |
1,057 |
$90.81 |
| 97166 |
|
51 |
46 |
$87.48 |
| 93325 |
|
37 |
36 |
$87.21 |
| 82378 |
|
25 |
24 |
$86.19 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
18,939 |
18,108 |
$85.91 |
| 87075 |
|
270 |
235 |
$85.38 |
| A6258 |
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
13,355 |
12,470 |
$85.22 |
| 86038 |
|
3,049 |
2,899 |
$83.98 |
| 87481 |
|
306 |
295 |
$80.72 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
10,453 |
8,936 |
$78.90 |
| 84460 |
|
879 |
847 |
$78.82 |
| A4649 |
Surgical supply; miscellaneous |
215 |
132 |
$76.95 |
| 87653 |
|
155 |
154 |
$76.67 |
| J2060 |
Injection, lorazepam, 2 mg |
7,556 |
5,967 |
$76.41 |
| 84100 |
|
9,638 |
7,183 |
$76.00 |
| 84481 |
|
977 |
940 |
$73.35 |
| 86160 |
|
1,761 |
893 |
$71.33 |
| J1790 |
Injection, droperidol, up to 5 mg |
1,836 |
1,696 |
$70.18 |
| 85652 |
|
10,069 |
9,569 |
$65.08 |
| A6206 |
Contact layer, sterile, 16 sq. in. or less, each dressing |
109 |
102 |
$62.73 |
| 83540 |
|
6,003 |
5,602 |
$62.57 |
| 84132 |
|
414 |
365 |
$62.14 |
| 97016 |
|
7,158 |
3,190 |
$61.95 |
| J1815 |
Injection, insulin, per 5 units |
7,392 |
3,500 |
$60.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14,917 |
13,291 |
$57.78 |
| 86709 |
|
592 |
565 |
$55.45 |
| J1630 |
Injection, haloperidol, up to 5 mg |
4,644 |
3,830 |
$51.06 |
| 82670 |
|
283 |
274 |
$50.44 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
307 |
296 |
$49.42 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
8,452 |
8,336 |
$47.52 |
| 82785 |
|
616 |
581 |
$45.05 |
| Q0114 |
Fern test |
1,780 |
1,658 |
$43.78 |
| 88300 |
|
562 |
503 |
$38.08 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
8,090 |
6,811 |
$37.18 |
| 85014 |
|
2,419 |
2,184 |
$34.27 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
7,905 |
7,430 |
$32.75 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,592 |
2,969 |
$32.50 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,438 |
1,767 |
$31.38 |
| 82248 |
|
2,080 |
1,734 |
$30.88 |
| 94645 |
|
55 |
54 |
$30.80 |
| 82103 |
|
415 |
410 |
$30.63 |
| 82947 |
|
343 |
307 |
$28.27 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,958 |
1,476 |
$27.91 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,009 |
3,501 |
$26.47 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
3,224 |
3,117 |
$26.45 |
| 80047 |
|
1,062 |
1,019 |
$25.90 |
| 82043 |
|
11,497 |
10,926 |
$25.39 |
| 84295 |
|
106 |
90 |
$23.94 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,026 |
947 |
$23.66 |
| 94760 |
|
802 |
586 |
$23.26 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,715 |
1,447 |
$21.50 |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,164 |
2,375 |
$21.23 |
| C1729 |
Catheter, drainage |
512 |
310 |
$20.12 |
| G0379 |
Direct admission of patient for hospital observation care |
516 |
469 |
$19.66 |
| 86359 |
|
5,632 |
5,217 |
$19.21 |
| 83002 |
|
188 |
181 |
$19.17 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
1,130 |
879 |
$18.96 |
| 36600 |
|
136 |
125 |
$18.16 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
10,516 |
9,797 |
$17.93 |
| 76937 |
|
249 |
233 |
$16.89 |
| 86256 |
|
125 |
123 |
$15.39 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
7,225 |
5,858 |
$14.84 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
4,313 |
3,516 |
$14.67 |
| 82390 |
|
367 |
356 |
$14.08 |
| 85384 |
|
136 |
124 |
$12.66 |
| 82977 |
|
610 |
579 |
$12.65 |
| 88740 |
|
446 |
428 |
$12.62 |
| J0456 |
Injection, azithromycin, 500 mg |
687 |
589 |
$11.96 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,386 |
1,351 |
$11.59 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
5,608 |
4,556 |
$11.25 |
| G0009 |
Administration of pneumococcal vaccine |
3,447 |
3,217 |
$11.19 |
| 90480 |
|
374 |
363 |
$11.02 |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,510 |
1,146 |
$10.72 |
| A6234 |
Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
286 |
240 |
$10.50 |
| 85046 |
|
643 |
594 |
$9.15 |
| 85018 |
|
194 |
160 |
$7.87 |
| 86593 |
|
1,513 |
1,440 |
$7.37 |
| 86308 |
|
98 |
96 |
$7.17 |
| J3360 |
Injection, diazepam, up to 5 mg |
366 |
333 |
$6.80 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,710 |
1,129 |
$6.77 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
313 |
289 |
$6.75 |
| 99152 |
|
1,458 |
1,365 |
$6.56 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
702 |
603 |
$6.46 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
622 |
584 |
$6.15 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
559 |
524 |
$5.99 |
| 90653 |
|
1,115 |
1,013 |
$5.45 |
| 84270 |
|
1,116 |
1,060 |
$5.12 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
127 |
123 |
$5.12 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,420 |
1,272 |
$4.97 |
| 84300 |
|
562 |
525 |
$4.52 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
4,086 |
3,643 |
$3.16 |
| 86200 |
|
1,339 |
1,287 |
$2.71 |
| 89050 |
|
213 |
209 |
$1.52 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
177 |
166 |
$0.93 |
| J2020 |
Injection, linezolid, 200 mg |
133 |
75 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
464 |
410 |
$0.00 |
| 87206 |
|
434 |
375 |
$0.00 |
| 83930 |
|
400 |
371 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
188 |
182 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,842 |
1,065 |
$0.00 |
| 82104 |
|
139 |
138 |
$0.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
296 |
279 |
$0.00 |
| 90674 |
|
672 |
585 |
$0.00 |
| 96415 |
|
786 |
571 |
$0.00 |
| 88307 |
|
653 |
519 |
$0.00 |
| G8983 |
Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting |
178 |
169 |
$0.00 |
| 76819 |
Fetal biophysical profile; without non-stress testing |
15 |
15 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
95 |
69 |
$0.00 |
| 89060 |
|
387 |
316 |
$0.00 |
| G8986 |
Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting |
2,384 |
2,156 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
472 |
412 |
$0.00 |
| 86376 |
|
457 |
438 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
44 |
39 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
698 |
660 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
60 |
57 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
127 |
127 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
554 |
529 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
683 |
644 |
$0.00 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
502 |
430 |
$0.00 |
| 80329 |
|
6,349 |
4,705 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
426 |
388 |
$0.00 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
39 |
38 |
$0.00 |
| 90474 |
|
168 |
142 |
$0.00 |
| 90697 |
|
48 |
48 |
$0.00 |
| A7521 |
Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each |
577 |
563 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
227 |
218 |
$0.00 |
| 90680 |
|
160 |
133 |
$0.00 |
| 0346T |
|
371 |
364 |
$0.00 |
| 86364 |
|
12 |
12 |
$0.00 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
80 |
80 |
$0.00 |
| 97014 |
|
623 |
327 |
$0.00 |
| 87593 |
|
13 |
12 |
$0.00 |
| 84154 |
|
12 |
12 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
16 |
15 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
188 |
188 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
287 |
218 |
$0.00 |
| 87046 |
|
42 |
41 |
$0.00 |
| 82945 |
|
38 |
38 |
$0.00 |
| 0012A |
|
63 |
63 |
$0.00 |
| 87015 |
|
314 |
275 |
$0.00 |
| 82553 |
|
341 |
306 |
$0.00 |
| 0011A |
|
71 |
71 |
$0.00 |
| C1781 |
Mesh (implantable) |
28 |
27 |
$0.00 |
| 84157 |
|
51 |
49 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
26 |
25 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
28 |
27 |
$0.00 |
| 80051 |
|
92 |
84 |
$0.00 |
| J1836 |
Injection, metronidazole, 10 mg |
441 |
288 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
604 |
538 |
$0.00 |
| 99406 |
|
42 |
39 |
$0.00 |
| 0031A |
|
27 |
27 |
$0.00 |
| 87529 |
|
29 |
25 |
$0.00 |
| 83935 |
|
29 |
27 |
$0.00 |
| 29130 |
|
12 |
12 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
42 |
28 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
15 |
15 |
$0.00 |
| 90723 |
|
26 |
26 |
$0.00 |
| 86701 |
|
13 |
13 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
59 |
44 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
30 |
25 |
$0.00 |
| 93320 |
|
12 |
12 |
$0.00 |
| 90632 |
|
14 |
13 |
$0.00 |
| 80177 |
|
13 |
12 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
23 |
22 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
113 |
93 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$0.00 |
| 86702 |
|
13 |
13 |
$0.00 |
| 82436 |
|
14 |
13 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
15 |
12 |
$0.00 |
| 97116 |
|
861 |
687 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,397 |
1,260 |
$0.00 |
| 77061 |
|
1,446 |
1,424 |
$0.00 |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
200 |
140 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
52 |
31 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
1,630 |
1,458 |
$0.00 |
| 76514 |
|
44 |
40 |
$0.00 |
| A4565 |
Slings |
2,593 |
2,492 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
279 |
274 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
1,570 |
1,400 |
$0.00 |
| 89051 |
|
834 |
692 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,535 |
1,389 |
$0.00 |
| 84450 |
|
860 |
829 |
$0.00 |
| 77062 |
|
2,331 |
2,282 |
$0.00 |
| 93225 |
|
712 |
703 |
$0.00 |
| 76981 |
|
2,299 |
2,234 |
$0.00 |
| 84155 |
|
287 |
279 |
$0.00 |
| D1120 |
Prophylaxis - child |
213 |
213 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
128 |
120 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
298 |
287 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
1,886 |
1,585 |
$0.00 |
| 92025 |
|
39 |
37 |
$0.00 |
| A0110 |
Non-emergency transportation and bus, intra or inter state carrier |
105 |
87 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
375 |
331 |
$0.00 |
| 94729 |
|
1,504 |
1,462 |
$0.00 |
| 88313 |
|
50 |
24 |
$0.00 |
| 84520 |
|
361 |
355 |
$0.00 |
| D0220 |
Intraoral - periapical first radiographic image |
727 |
713 |
$0.00 |
| 86705 |
|
105 |
99 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,261 |
1,740 |
$0.00 |
| J3372 |
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg |
111 |
79 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
251 |
219 |
$0.00 |
| 92611 |
|
251 |
243 |
$0.00 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
252 |
142 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
1,909 |
1,606 |
$0.00 |
| 85460 |
|
57 |
54 |
$0.00 |
| J7070 |
Infusion, d5w, 1000 cc |
217 |
128 |
$0.00 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
76 |
76 |
$0.00 |
| 96417 |
|
365 |
229 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
128 |
121 |
$0.00 |
| 86765 |
|
47 |
40 |
$0.00 |
| 94770 |
|
537 |
456 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
52 |
52 |
$0.00 |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
39 |
38 |
$0.00 |
| 90633 |
|
39 |
39 |
$0.00 |
| 86015 |
|
118 |
114 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
16 |
13 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
129 |
121 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
14 |
12 |
$0.00 |
| A0160 |
Non-emergency transportation: per mile - case worker or social worker |
69 |
27 |
$0.00 |
| 87324 |
|
105 |
102 |
$0.00 |
| T2003 |
Non-emergency transportation; encounter/trip |
63 |
24 |
$0.00 |
| 71100 |
|
13 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
58 |
52 |
$0.00 |
| 86787 |
|
31 |
26 |
$0.00 |
| 90648 |
|
35 |
35 |
$0.00 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
34 |
34 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
27 |
14 |
$0.00 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
47 |
37 |
$0.00 |
| 84133 |
|
43 |
41 |
$0.00 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
82 |
24 |
$0.00 |
| 86147 |
|
12 |
12 |
$0.00 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
21 |
16 |
$0.00 |
| 90682 |
|
44 |
44 |
$0.00 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
40 |
39 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
58 |
38 |
$0.00 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
15 |
12 |
$0.00 |
| 86735 |
|
15 |
14 |
$0.00 |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
39 |
39 |
$0.00 |
| 85060 |
|
14 |
14 |
$0.00 |